For the study, researchers from both agencies analyzed data submitted by 28 E.U. member states on multiple strains of bacteria with known drug-resistance commonly detected in humans and animals. Analysis revealed nearly 30 percent of Salmonella isolates extracted from humans displayed multidrug resistance. However, experts also found resistance to antimicrobials used to treat severe human cases of Salmonella infection remained low.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox
“It is of particular concern that some common types of Salmonella in humans, such as monophasic Salmonella Typhimurium, exhibit extremely high multidrug resistance,” said Dr. Mike Catchpole, the chief scientist at the ECDC. “Prudent use of antibiotics in human and veterinary medicine is extremely important to address the challenge posed by antimicrobial resistance. We all have a responsibility to ensure that antibiotics keep working.”
More articles on infection control:
California Red Cross emergency center sees outbreak of potential norovirus
Study: Listeria linked to miscarriage in early pregnancy
Anti-vaccine movement gains traction in Texas
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
